期刊
JOURNAL OF ANESTHESIA
卷 34, 期 5, 页码 729-740出版社
SPRINGER JAPAN KK
DOI: 10.1007/s00540-020-02823-6
关键词
Lung transplantation; Primary graft dysfunction; Reperfusion injury; Therapeutics
资金
- NIAA, London, UK
Primary graft dysfunction (PGD) is one of the most common complications in the early postoperative period and is the most common cause of death in the first postoperative month. The underlying pathophysiology is thought to be the ischaemia-reperfusion injury that occurs during the storage and reperfusion of the lung engraftment; this triggers a cascade of pathological changes, which result in pulmonary vascular dysfunction and loss of the normal alveolar architecture. There are a number of surgical and anaesthetic factors which may be related to the development of PGD. To date, although treatment options for PGD are limited, there are several promising experimental therapeutic targets. In this review, we will discuss the pathophysiology, clinical management and potential therapeutic targets of PGD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据